PREFERENTIAL INCREASE OF HETEROCHROMATIN IN VENULAR ENDOTHELIUM OF LUNG IN MICE AFTER ADMINISTRATION OF DIMETHYLARSINIC ACID, A MAJOR METABOLITE OF INORGANIC ARSENICS

被引:21
作者
NAKANO, M
YAMANAKA, K
HASEGAWA, A
SAWAMURA, R
OKADA, S
机构
[1] NIHON UNIV,COLL PHARM,DEPT BIOCHEM TOXICOL,FUNABASHI,CHIBA 274,JAPAN
[2] NIHON UNIV,COLL PHARM,DEPT HYG CHEM,FUNABASHI,CHIBA 274,JAPAN
[3] UNIV SHIZUOKA,SCH PHARMACEUT SCI,DEPT RADIOBIOCHEM,SHIZUOKA 422,JAPAN
关键词
D O I
10.1093/carcin/13.3.391
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Dimethylarsinic acid (DMAA) administration induced the preferential increase of the heterochromatic area forming the inside of the interphase nucleus. A histopathological study of the lung and liver in mice after DMAA administration was carried out by transmission electron microscopy. Ultrastructural alterations in the endothelial nuclei of the alveolar wall were observed 12-48 h after administration. Heterochromatin tended to collect in a dense, compact mass lining the inner walls of the nucleus. A significant increase in heterochromatin induced by DMAA administration was observed by morphometric analysis. However, no substantial differences appeared in the sinusoidal endothelium of the liver. This study suggests that the much greater induction of morphological alterations, such as increased heterochromatin, in lung endothelial nuclei than in the liver might explain the high risk of lung cancer by arsenics, and that there may be a close relationship between heterochromatin alteration and DNA damages.
引用
收藏
页码:391 / 393
页数:3
相关论文
共 28 条
[1]   BIOTRANSFORMATION AND INTRACELLULAR BINDING OF ARSENIC IN TISSUES OF RABBITS AFTER INTRAPERITONEAL ADMINISTRATION OF AS-74 LABELED ARSENITE [J].
BERTOLERO, F ;
MARAFANTE, E ;
RADE, JE ;
PIETRA, R ;
SABBIONI, E .
TOXICOLOGY, 1981, 20 (01) :35-44
[2]   COMPARISON OF THE URINARY-EXCRETION OF ARSENIC METABOLITES AFTER A SINGLE ORAL DOSE OF SODIUM ARSENITE, MONOMETHYLARSONATE, OR DIMETHYLARSINATE IN MAN [J].
BUCHET, JP ;
LAUWERYS, R ;
ROELS, H .
INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH, 1981, 48 (01) :71-79
[3]   METABOLISM OF ORALLY-ADMINISTERED INORGANIC ARSENIC IN THE DOG [J].
CHARBONNEAU, SM ;
TAM, GKH ;
BRYCE, F ;
ZAWIDZKA, Z ;
SANDI, E .
TOXICOLOGY LETTERS, 1979, 3 (02) :107-113
[4]   WHOLE-BODY RETENTION, EXCRETION AND METABOLISM OF [AS-74]ARSENIC ACID IN THE HAMSTER [J].
CHARBONNEAU, SM ;
HOLLINS, JG ;
TAM, GKH ;
BRYCE, F ;
RIDGEWAY, JM ;
WILLES, RF .
TOXICOLOGY LETTERS, 1980, 5 (3-4) :175-182
[5]  
CICCARELLI RB, 1981, CANCER LETT, V12, P349, DOI 10.1016/0304-3835(81)90178-6
[7]   CHANGES IN CHEMICAL SPECIATION OF ARSENIC FOLLOWING INGESTION BY MAN [J].
CRECELIUS, EA .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1977, 19 (AUG) :147-150
[8]  
FAIRCHILD EJ, 1977, REGISTRY TOXIC EFFEC
[9]  
LENDLE L, 1959, Klin Wochenschr, V37, P1230, DOI 10.1007/BF01486385
[10]   BIOSYNTHESIS OF DIMETHYLARSINE BY METHAANOBACTERIUM [J].
MCBRIDE, BC ;
WOLFE, RS .
BIOCHEMISTRY, 1971, 10 (23) :4312-&